Quantcast
Last updated on April 17, 2014 at 9:30 EDT

Latest Surface plasmon resonance Stories

2013-04-04 08:28:43

Patent for Ultra-Sensitive In-Vitro and POC Diagnostic Technology Platform MENLO PARK, Calif., April 4, 2013 /PRNewswire/ -- LamdaGen Corporation, a nano-technology platform company that provides plasmonic sensors and systems for diagnostics and life sciences, announced the Japanese Patent Office issuance of patent number 5203390, "Enzymatic Assays for LSPR", which enables highly sensitive and quantitative diagnostics. "The issuance of this patent underscores LamdaGen's unique...

2013-02-27 16:27:05

BOULDER, Colo. and HUNTINGTON BEACH, Calif., Feb. 27, 2013 /PRNewswire/ -- BiOptix is highlighting new and compelling small molecule kinetics data from the new BiOptix 404pi at the IBC Biopharmaceutical Development & Production Week to be held from February 25 - March 1 2013 in Huntington Beach, CA. These new data sets continue to underscore the versatility of the BiOptix 404pi, an SPR instrument that is built for both protein-protein kinetics as well as protein-small molecule...

Ancient Roman Cup Is Inspiration For The World's Most Sensitive Plasmon Resonance Sensor
2013-02-14 15:58:29

University of Illinois College of Engineering Utilizing optical characteristics first demonstrated by the ancient Romans, researchers at the University of Illinois at Urbana-Champaign have created a novel, ultra-sensitive tool for chemical, DNA, and protein analysis. "With this device, the nanoplasmonic spectroscopy sensing, for the first time, becomes colorimetric sensing, requiring only naked eyes or ordinary visible color photography," explained Logan Liu, an assistant professor of...

2013-02-12 16:23:18

BOULDER, Colo., and SAN FRANCISCO, Feb. 12, 2013 /PRNewswire/ -- BiOptix in conjunction with Molecular Med TRI-CON 2013 will officially announce the expansion of the BiOptix Innovators Program, a unique-to-the-industry "try before you buy" instrument demo program that encourages researchers and institutions to become acquainted with the new BiOptix 404pi, the first commercially available SPR instrument to incorporate phase-based common path interferometry technology. During the event, Ken...

2013-01-16 23:01:26

Plexera®, LLC, a worldwide provider of label-free surface plasmon resonance imaging (SPRi) technology solutions for functional proteomics, announced today the official launch of its contract research effort based in offices of Plexera LLC located at the Institute for Systems Biology (ISB). Plexera will perform advanced kinetic interaction analysis on either customer provided samples or Plexera provided targets and libraries. Seattle Washington (PRWEB) January 16, 2013 Plexera®, LLC,...

2012-12-03 12:28:01

BOULDER, Colo. and SAN DIEGO, Dec. 3, 2012 /PRNewswire/ -- BiOptix announced today that it will be showcasing the new BiOptix 404pi at IBC's 23(rd) Annual Antibody Engineering and Therapeutics Conference in San Diego. The conference, which runs December 2 - 6, 2012, is one of the preeminent technology symposia in the world for the international antibody development and research community. "The new BiOptix 404pi, the first commercially available SPR instrument to incorporate phase-based...

2012-11-01 11:27:48

BOULDER, Colo., AMSTERDAM and VIENNA, Nov. 1, 2012 /PRNewswire/ -- BiOptix today announced that it would be highlighting the new BiOptix 404pi, the first commercially available SPR instrument to incorporate phase-based common path interferometry technology, at the Label Free Technologies Show in Amsterdam from November 1 - 3 as well as at the PEGS Europe Summit on November 6 - 8. "At the Label Free and PEGS Europe meetings, BiOptix will unveil new application data that demonstrates...

2012-10-25 11:30:07

BOULDER, Colo. and MOUNTAIN VIEW, Calif., Oct. 25, 2012 /PRNewswire/ -- BiOptix today announced the BiOptix Innovators Program, a pioneering instrument trial program that encourages researchers and institutions to become acquainted with the upcoming BiOptix 404pi, the first commercially available SPR instrument to incorporate phase-based common path interferometry technology. BiOptix announced the new program while participating in Russian Innovation Week, held at the Computer History...

2012-09-24 02:27:34

BOULDER, Colo. and BASEL, Switzerland, Sept. 24, 2012 /PRNewswire/ -- BiOptix officially announced that it has expanded sales and marketing efforts outside of the United States and into Europe with participation in MipTec, The Leading European Event for Drug Discovery. MipTec is being held at Congress Center Basel, in Basel, Switzerland from September 24 - 27, 2012. "MipTec is the ideal venue to launch our European Sales and Marketing efforts," noted Ken Wilczek, Vice President of...

2012-09-11 02:29:29

BOULDER, Colo., September 11, 2012 /PRNewswire/ -- BiOptix announced continued support of the Colorado BioScience Association today, with participation in BioWest 2012, a leading life sciences showcase event in Colorado to be held at the Denver Marriott City Center. "BiOptix continues to believe in the goals and community that is fostered by the Colorado BioScience Association, noted Rick Whitcomb, President and CEO of BiOptix. "As Colorado continues to expand its footprint in the...